Tissue engineering therapy for cardiovascular disease

Circulation Research

Volumn 92, Issue 10, 2003, Pages 1068-1078

  Nugent, Helen M ^a,c   Edelman, Elazer R ^a,b  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cardiomyoplasty; Cardiovascular system; Heart valves; Tissue engineering; Vascular grafts

Indexed keywords

DACRON; PERFLUORO COMPOUND; POLITEF; POLYETHYLENE TEREPHTHALATE; POLYMACON; POLYMER; POLYURETHAN; POLYVINYLCHLORIDE;

BLOOD VESSEL GRAFT; CARDIOMYOPLASTY; CARDIOVASCULAR DISEASE; CELL TRANSPLANTATION; GENE TRANSFER; GENETIC MANIPULATION; HEART VALVE; HUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REPAIR;

ANIMALS; CARDIOMYOPLASTY; CARDIOVASCULAR DISEASES; CELL TRANSPLANTATION; GENE THERAPY; HEART VALVE DISEASES; HUMANS; MYOCARDIAL REVASCULARIZATION; TISSUE ENGINEERING;

EID: 0038728411     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000073844.41372.38     Document Type: Review

References (135)

1. Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2002.
2. Collaborative overview of randomised trials of antiplatelet therapy, III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients: Antiplatelet Trialists' Collaboration. BMJ. 1994;308:235-246.
3. Bos GW, Poot AA, Geugeling T, van Aken WG, Feijen J. Small-diameter vascular graft prostheses: current status. Arch Physiol Biochem. 1998;106:100-115.
4. Pevec WC, Darling RC, L'Italien GJ, Abbott WM. Femoropopliteal reconstruction with knitted, nonvelour Dacron versus expanded polytetrafluoroethylene. J Vasc Surg. 1992;16:60-65.
5. Herring M, Gardner A, Glover J. A single staged technique for seeding vascular grafts with autologous endothelium. Surgery. 1978;84:498-504.
6. Herring M, Gardner A, Glover J. Seeding endothelium onto canine arterial prostheses: the effects of graft design. Arch Surg. 1979; 114:679-682.
7. Herring MB, Dilley R, Jersild RA, Boxer L, Gardner A, Glover J. Seeding arterial prostheses with vascular endothelium: the nature of the lining. Ann Surg. 1979;190:84-90.
8. Graham LM, Vinter DW, Ford JW, Kahn RH, Burkel WE, Stanley JC. Cultured autogenous endothelial cell seeding of prosthetic vascular grafts. Surg Forum. 1979;30:204-206.
9. Graham LM, Vinter DW, Ford JW, Kahn RH, Burkel WE, Stanley JC. Endothelial cell seeding of prosthetic vascular grafts: early experimental studies with cultured autologous canine endothelium. Arch Surg. 1980; 115:929-933.
10. Graham LM, Burkel WE, Ford JW, Vinter DW, Kahn RH, Stanley JC. Expanded polytetrafluoroethylene vascular prostheses seeded with enzymatically derived and cultured canine endothelial cells. Surgery. 1982; 91:550-559.
11. Schmidt SP, Hunter TJ, Sharp WV, Malindzak GS, Evancho MM. Endothelial cell-seeded four-millimeter Dacron vascular grafts: effects of blood flow manipulation through the grafts. J Vasc Surg. 1984;1:434-441.
12. Schmidt SP, Hunter TJ, Hirko M, Belden TA, Evancho MM, Sharp WV, Donovan DL. Small-diameter vascular prostheses: two designs of PTFE and endothelial cell-seeded and nonseeded Dacron. J Vasc Surg. 1985; 2:292-297.
13. van Wachem PB, Beugeling T, Feijen J, Bantjes A, Detmers JP, van Aken WG. Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities. Biomaterials. 1985;6:403-408.
14. van Wachem PB, Hogt AH, Beugeling T, Feijen J, Bantjes A, Detmers JP, van Aken WG. Adhesion of cultured human endothelial cells onto methacrylate polymers with varying surface wettability and charge. Biomaterials. 1987;8:323-328.
15. McAuslan BR, Johnson G. Cell responses to biomaterials, I: adhesion and growth of vascular endothelial cells on poly(hydroxyethyl methacrylate) following surface modification by hydrolytic etching. J Biomed Mater Res. 1987;21:921-935.
16. Ramires PA, Mirenghi L, Romano AR, Palumbo F, Nicolardi G. Plasma-treated PET surfaces improve the biocompatibility of human endothelial cells. J Biomed Mater Res. 2000;51:535-539.
17. Absolom DR, Hawthorn LA, Chang G. Endothelialization of polymer surfaces. J Biomed Mater Res. 1988;22:271-285.
18. McAuslan BR, Johnson G, Hannan GN, Norris WD, Exner T. Cell responses to biomaterials, II: endothelial cell adhesion and growth on perfluorosulfonic acid. J Biomed Mater Res. 1988;22:963-976.
19. Steele JG, Johnson G, Norris WD, Underwood PA. Adhesion and growth of cultured human endothelial cells on perfluorosulphonate: role of vitronectin and fibronectin in cell attachment. Biomaterials. 1991;12:531-539.
20. Wigod MD, Klitzman B. Quantification of in vitro endothelial cell adhesion to vascular graft material. J Biomed Mater Res. 1993;27:1057-1062.
21. Brunstedt MR, Ziats NP, Rose-Caprara V, Hiltner PA, Anderson JM, Lodoen GA, Payet CR. Attachment and proliferation of bovine aortic endothelial cells onto additive modified poly(ether urethane ureas). J Biomed Mater Res. 1993;27:483-492.
22. Zhang JC, Wojta J, Binder BR. Growth and fibrinolytic parameters of human umbilical vein endothelial cells seeded onto cardiovascular grafts. J Thorac Cardiovasc Surg. 1995;109:1059-1065.
23. Storck J, Razek H, Zimmerman ER. Effect of polyvinyl chloride plastic on the growth and physiology of human umbilical vein endothelial cells. Biomaterials. 1996;17:1791-1794.
24. Cenni E, Granchi D, Ciapetti G, Verri E, Cavedagna D, Gamberini S, Cervellati M, Di Leo A, Pizzoferrato A. Expression of adhesion molecules on endothelial cells after contact with knitted Dacron. Biomaterials. 1997;18:489-494.
25. Cenni E, Granchi D, Ciapetti G, Verri E, Cavedagna D, Gamberini S, Di Leo A, Pizzoferrato A. Cytokine production and adhesive protein expression by endothelial cells after contact with polyethylene terephthalate. Biomaterials. 1996;17:2071-2076.
26. Yeager A, Callow AD. New graft materials and current approaches to an acceptable small diameter vascular graft. ASAIO Trans. 1988;34:88-94.
27. Massia SP, Hubbell JA. Human endothelial cell interactions with surface-coupled adhesion peptides on a nonadhesive glass substrate and two polymeric biomaterials. J Biomed Mater Res. 1991;25:223-242.
28. Cheresh DA. Human endothelial cells synthesize and express ArgGly-Asp directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA. 1987;84:6471-6475.
29. Dejana E, Languino LR, Colella S, Corbascio GC, Plow E, Ginsberg M, Marchisio PC. The localization of platelet gbIIb-IIIa-related protein in endothelial cell adhesion structures. Blood. 1988;71:566-572.
30. Charo IF, Bekeart LS, Philips DR. Platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix. J Biol Chem. 1987;262:9935-9938.
31. Holland J, Hersh L, Bryhan M, Onyiriuka E, Ziegler L. Culture of human vascular endothelial cells on an RGD-containing synthetic peptide attached to a starch-coated polystyrene surface: comparison with fibronectin-coated tissue culture grade polystyrene. Biomaterials. 1996; 17:2147-2156.
32. Hubbell JA, Massia SP, Desai NP, Drumheller PD. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechniques. 1991;9:568-572.
33. Massia SP, Hubbell JA. Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin α4β1. J Biol Chem. 1992;267:14019-14026.
34. Tiwari A, Salacinski HJ, Punshon G, Hamilton G, Seifalian AM. Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J. 2002;16:791-796.
35. Zilla P, Deutsch M, Meinhart J, Puschmann R, Eberl T, Minar E, Dudczak R, Lugmaier H, Schmidt P, Noszian I. Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg. 1994;19:540-548.
36. Meinhart J, Deutsch M, Zilla P. Eight years of clinical endothelial cell transplantation: closing the gap between prosthetic grafts and vein grafts. ASAIO J. 1997;43:M515-M521.
37. Deutsch M, Meinhart J, Fischlein T, Preiss P, Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery. 1999;126:847-855.
38. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg. 2001;71:S327-S331.
39. Zilla P, Fasol R, Deutsch M, Fischlein T, Minar E, Hammerle A, Krupicka O, Kadletz M. Endothelial cell seeding of polytetrafluoroethylene vascular grafts in humans: a preliminary report. J Vasc Surg. 1987;6:535-541.
40. Karube N, Soma T, Noishiki Y, Yamazaki I, Kosuge T, Ichikawa Y, Takanashi Y. Clinical long-term results of vascular prosthesis sealed with fragmented autologous adipose tissue. Artif Organs. 2001;25:218-222.
41. Weinberg CB, Bell E. Regulation of proliferation of bovine aortic endothelial cells, smooth muscle cells, and dermal fibroblasts in collagen lattices. J Cell Physiol. 1985;122:410-414.
42. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science. 1986;231:397-400.
43. Teebken OE, Bader A, Steinhoff G, Haverich A. Tissue engineering of vascular grafts: human cell seeding of decellularized porcine matrix. Eur J Vasc Endovasc Surg. 2000;19:381-386.
44. Goldstein S, Clarke DR, Walsh SP, Black KS, O'Brien MF. Transpecies heart valve transplant: advanced studies of a bioengineered xenoautograft. Ann Thorac Surg. 2000;70:1962-1969.
45. Schmidt CE, Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials. 2000;21:2215-2231.
46. Yannas IV. Natural materials. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, eds. Biomaterials Science. San Diego, Calif: Academic Press; 1996:84-94.
47. O'Brien TK, Gabbay S, Parkes AC, Knight RA, Zalesky PJ. Immunological reactivity to a new glutaraldehyde tanned bovine pericardial heart valve. Trans Am Soc Artif Intern Organs. 1984;30:440-444.
48. Dahm M, Lyman WD, Schwell AB, Factor SM, Frater RW. Immunogenicity of glutaraldehyde-tanned bovine pericardium. J Thorac Cardiovasc Surg. 1990;99:1082-1090.
49. Pereira CA, Lee JM, Haberer SA. Effect of alternative crosslinking methods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material. J Biomed Mater Res. 1990;24:345-361.
50. Schmitz-Rixen T, Megerman J, Anderson JM, Warnock DF, L'Italien GJ, Erasmi H, Horsch S, Abbott WM. Long-term study of a compliant biological vascular graft. Eur J Vasc Surg. 1991;5:149-158.
51. Naimark WA, Pereira CA, Tsang K, Lee JM. HMDC crosslinking of bovine pericardial tissue: a potential role of the solvent environment in the design of bioprosthetic material. J Mater Sci Mater Med. 1995;6:235-241.
52. Rao KP, Shanthi C. Reduction of calcification by various treatments in cardiac valves. J Biomater Appl. 1999;13:238-268.
53. Ma XH, Noishiki Y, Yamane Y, Iwai Y, Marato D, Matsumoto A. Thermal cross-linking for biologically degradable materials: preliminary report. ASAIO J. 1996;42:M866-M871.
54. Badylak SF, Lantz GC, Coffey A. Small intestine submucosa as a large-diameter vascular graft in the dog. J Surg Res. 1989;47:74-80.
55. Lantz GC, Badylak SF, Coffey AC. Small intestine submucosa as a small-diameter vascular graft in dogs. J Invest Surg. 1990;3:217-227.
56. Sandusky GE, Badylak SF, Morff RJ. Histological findings after in-vivo placement of small-intestine submucosa vascular grafts and saphenous vein grafts in the carotid artery in dogs. Am J Pathol. 1992; 140:317-324.
57. Lantz GC, Badylak SF, Hiles MC, Coffey AC, Geddes LA, Kokini K, Sandusky GE, Morff RJ. Small intestine submucosa as a vascular graft: a review. J Invest Surg. 1993;19:465-472.
58. Prevel CD, Eppley BL, McCarty M, Jackson JR, Voytik SL, Hiles MC, Badylak SF. Experimental evaluation of small intestinal submucosa as a microvascular graft material. Microsurgery. 1994;15:586-591.
59. Huynh T, Abraham G, Murray J, Brockbank K, Hagen PO, Sullivan S. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol. 1999;17:1083-1086.
60. Bengtsson LA, Phillips R, Haegerstrand AN. In vitro endothelialization of photooxidatively stabilized xenogeneic pericardium. Ann Thorac Surg. 1995;60(suppl 2):S365-S368.
61. Lalka SG, Oelker LM, Malone JM, Duhamel RC, Kevorkian MA, Raper BA, Nixon JC, Etchberger KJ, Dalsing MC, Cikrit DF. Acellular vascular matrix: a natural endothelial cell substrate. Ann Vasc Surg. 1989;3:108-117.
62. Grabenwoger M, Grimm M, Eybl E, Moritz A, Muller MM, Bock P, Wolner E. Endothelial cell lining of bioprosthetic heart valve material. J Card Surg. 1992;7:79-84.
63. Curtil A, Pegg DE, Wilson A. repopulation of freeze-dried porcine valves with human fibroblasts and endothelial cells. J Heart Valve Dis. 1997;6:296-306.
64. Lamm P, Juchem G, Weyrich P, Nees S, Reichart B. New alternative coronary bypass graft: first clinical experience with an autologous endothelialized cryopreserved allograft. J Thorac Cardiovasc Surg. 1999; 117:1217-1219.
65. Dixit P, Hern-Anderson D, Ranieri J, Schmidt CE. Vascular graft endothelialization: comparative analysis of canine and human endothelial cell migration on natural biomaterials. J Biomed Mater Res. 2001;56:545-555.
66. Shinoka T, Shum-Tim D, Ma P, Tanel R, Isogai N, Langer R, Vacanti J, Mayer J. Creation of viable pulmonary autografts through tissue engineering. J Cardiovasc Thorac Surg. 1998;115:536-545.
67. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science. 1999;284:489-493.
68. L'Heureux N, Paquet S, Labbe R, Germain L, Auger F. A completely biological tissue-engineered human blood vessel. FASEB J. 1998;12:47-56.
69. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res. 1999;85:1173-1178.
70. Nathan A, Nugent MA, Edelman ER. Tissue engineered perivascular endothelial cell implants regulate vascular injury. Proc Natl Acad Sci USA. 1995;92:8130-8134.
71. Nugent HM, Rogers C, Edelman ER. Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ Res. 1999;84:384-391.
72. Nugent MA, Nugent HM, Iozzo RV, Sanchack K, Edelman ER. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc Natl Acad Sci U S A. 2000;97:6722-6727.
73. Nugent HM, Edelman ER. Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury. J Surg Res. 2001;99:228-234.
74. Nugent HM, Groothius A, Seifert P, Guerraro L, Nedelman M, Mohanakumar T, Edelman ER. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res. 2002;39:524-533.
75. Schoen FJ, Levy RJ. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999;47:439-465.
76. Vongpatanasin W, Hillis D, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;335:407-416.
77. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis: Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med. 1993;328:1289-1296.
78. Mayer JE. Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Semin Thorac Cardiovasc Surg. 1995;7:130-132.
79. Yacoub M, Rasmi NR, Sundt TM, Lund O, Boyland E, Radley-Smith R, Khaghani A, Mitchell A. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg. 1995;110:186-193.
80. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogeneic acellular matrix conduits. Circulation. 2000; 102(suppl III):III-50-III-55.
81. Mann BK, West JL. Tissue engineering in the cardiovascular system: progress toward a tissue engineered heart. Anat Rec. 2001;263:367-371.
82. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE. Functional living trileaflet heart valves grown in vitro. Circulation. 2000;102(suppl III):III-44-III-49.
83. Taylor DA. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure. Curr Control Trials Cardiovasc Med. 2001;2:208-210.
84. Canver CC, Chanda J. Heart transplantation. Ann Thorac Surg. 2001; 72:658-660.
85. Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, Macris MP, Delgado R, Buja LM. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62:675-681.
86. Miyagawa S, Sawa Y, Taketani S, Kawaguchi N, Nakamura T, Matsuura N, Matsuda H. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation. 2002;105:2556-2561.
87. Koh GY, Soonpaa MH, Klug MG, Field LJ. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol. 1993;264:HI727-HI733.
88. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4:929-933.
89. Marelli D, Desrosiers C, El-Alfy M, Kao RL, Chiu RC. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant. 1992;1:383-390.
90. Kessler PD, Byrne BJ. Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu Rev Physiol. 1999;61:219-242.
91. Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, Yau TM. Survival and function of bioengineered cardiac grafts. Circulation. 1999;100(suppl II):II-63-II-69.
92. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embryonic stem cells from stable intracardiac grafts. J Clin Invest. 1996;98:216-224.
93. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.
94. Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol. 1999;31:513-522.
95. Robinson SW, Cho PW, Levitsky HI, Olson JL, Hruban RH, Acker MA, Kessler PD. Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts. Cell Transplant. 1996;5:77-91.
96. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 1996;98:2512-2523.
97. Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant. 2000;9:359-368.
98. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg. 2000;120:999-1005.
99. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg. 1995;60:12-18.
100. Atkins BZ, Hueman MT, Meuchel JM, Cottman MJ, Hutcheson KA, Taylor DA. Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. J Heart Lung Transplant. 1999;18:1173-1180.
101. Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg. 2001;121:871-878.
102. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol. 2002;34:241-249.
103. Hagege AA, Vilquin JT, Bruneval P, Menasche P. Regeneration of the myocardium: a new role in the treatment of ischemic heart disease? Hypertension. 2001;38:1413-1415.
104. Menasche P. Myoblast transplantation: feasibility, safety and efficacy. Ann Med. 2002;34:314-315.
105. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science. 1994;264:98-101.
106. Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata Y, Komeda M. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg. 2002;124:50-56.
107. Reinlib L, Field L. Cell transplantation as future therapy for cardiovascular disease?: a workshop of the National Heart, Lung, and Blood Institute. Circulation. 2000;101:e182-e187.
108. Semsarian C. Stem cells in cardiovascular disease: from cell biology to clinical therapy. Intern Med J. 2002;32:259-265.
109. Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs. 2001;25:187-193.
110. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, Allidina Y, Liu P, Li RK. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 2002;123:1132-1140.
111. Zimmermann WH, Schneiderbanger K, Schubert P, Didie M, Munzel F, Heubach JF, Kostin S, Neuhuber WL, Eschenhagen T. Tissue engineering of a differentiated cardiac muscle construct. Circ Res. 2002;90: 223-230.
112. Leor JL, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, Granot Y, Cohen S. Bioengineered cardiac grafts: a new approach to repair the infracted myocardium? Circulation. 2000;102(suppl III):III-56-III-61.
113. Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K, Kikuchi A, Umezu M, Okano T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res. 2002;90: e40-e48.
114. Shimizu T, Yamato M, Akutsu T, Shibata T, Isoi Y, Kikuchi A, Umezu M, Okano T. Electrically communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocyte sheets. J Biomed Mater Res. 2002;60:110-117.
115. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DA, Li R-K. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation. 2001;104(suppl I):I-218-I-222.
116. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97:3422-3427.
117. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634-637.
118. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, Mayer JE. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med. 2001;7:1035-1040.
119. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation. 2002;105:732-738.
120. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2002;99:4391-4396.
121. Hoerstrup SP, Zund G, Schoeberlein A, Ye Q, Vogt PR, Turina M. Fluorescence activated cell sorting: a reliable method in tissue engineering of a bioprosthetic heart valve. Ann Thorac Surg. 1998;66: 1653-1657.
122. Stock UA, Vacanti JP, Mayer JE, Wahlers T. Tissue engineering of heart valves: current aspects. Thorac Cardiovasc Surg. 2002;50:184-1193.
123. Marler JJ, Upton J, Langer R, Vacanti J. Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev. 1998;33:165-182.
124. Walluscheck KP, Steinhoff G, Haverich A. Endothelial cell seeding of de-endothelialised human arteries: improvement by adhesion molecule induction and flow-seeding technology. Eur J Vasc Endovasc Surg. 1996;12:46-53.
125. Caplice NM. The artificial artery. Curr Interv Cardiol Rep. 2000; 2:7-10.
126. Ott MJ, Ballermann BJ. Shear stress-conditioned, endothelial cellseeded vascular grafts: improved cell adherence in response to in vitro shear stress. Surgery. 1995;117:334-339.
127. Ott MJ, Ballermann BJ. Adhesion and differentiation of endothelial cells by exposure to chronic shear stress: a vascular graft model. Blood Purif. 1995;13:125-134.
128. Stock UA, Vacanti JP. Cardiovascular physiology during fetal development and implications for tissue engineering. Tissue Eng. 2001;7:1-7.
129. Papadaki M, McIntire LV, Eskin SG. Effects of shear stress on the growth kinetics of human aortic smooth muscle cells in vitro. Biotechnol Bioeng. 1996;50:555.
130. Vouyouka AG, Powell RJ, Ricotta J, Chen H, Dudrick DJ, Sawmiller CJ, Dudrick SJ, Sumpio BE. Ambient pulsatile pressure modulates endothelial cell proliferation. J Mol Cell Cardiol. 1998;30:609-615.
131. Ochoa ER, Vacanti JP. An overview of the pathology and approaches to tissue engineering. Ann N Y Acad Sci. 2002;979:10-26.
132. Kaihara S, Borenstein J, Koka R, Lalan S, Ochoa ER, Ravens M, Pien H, Cunningham B, Vacanti JP. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng. 2000;6:105-117.
133. Frame MD, Sarelius IH. A system for culture of endothelial cells in 20-50-microns branching tubes. Microcirculation. 1995;2:377-385.
134. Anderson JR, Chiu DT, Jackman RJ, Cherniavskaya O, McDonald JC, Wu H, Whitesides SH, Whitesides GM. Fabrication of topologically complex three-dimensional microfluidic systems in PDMS by rapid prototyping. Anal Chem. 2000;72:3158-3164.
135. Chiu DT, Jeon NL, Huang S, Kane RS, Wargo CJ, Choi IS, Ingber DE, Whitesides GM. Patterned deposition of cells and proteins onto surfaces by using three-dimensional microfluidic systems. Proc Natl Acad Sci U S A. 2000;97:2408-2413.